Dexcom Aktie
WKN: A0D9T1
ISIN: US2521311074 Land: USA
boerse.de Prädikat:
aktueller Kurs:
334,70 EUR
Veränderung:
1,30 EUR
Veränderung in %:
0,39 %

Top
10

250

1

BOTSI®-Trendmonitor
vom 19. April 2021
Dexcom auf Rang 213

weitere Analysen einblenden

Dexcom Schedules Fourth Quarter and Full Year 2020 Earnings Release and Conference Call for February 11, 2021 at 4:30 p.m. Eastern Time

Dienstag, 19.01.21 14:30
Newsbild
Bildquelle: Fotolia

SAN DIEGO –

DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its fourth quarter and full year 2020 financial results after market close on Thursday, February 11, 2020. Management will hold a conference call to review the company's fourth quarter and full year 2020 performance starting at 4:30 p.m. (Eastern Time) on the same day. The conference call will be concurrently webcast. The link to the webcast will be available on the DexCom, Inc. investor relations website at investors.dexcom.com and will be archived there for future reference.

To listen to the conference call, please dial (800) 446-1671 (US/Canada) or (847) 413-3362 (International) and use the confirmation number "49591481" approximately five minutes prior to the start time.

About DexCom, Inc.

DexCom, Inc. empowers people to take control of diabetes through innovative continuous glucose monitoring (CGM) systems. Headquartered in San Diego, California, Dexcom has emerged as a leader of diabetes care technology. By listening to the needs of users, caregivers, and providers, Dexcom simplifies and improves diabetes management around the world.



Quelle: Business Wire



© 1994-2021 by boerse.de - Quelle für Kurse und Daten: ARIVA.DE AG - boerse.de übernimmt keine Gewähr